The Human Rights and Rights to Religious Freedom of 600,000 Japanese Citizens are at Risk
September 19, 2023 22:04 ET
|
Center for Studies on New Religions, "Bitter Winter"
Washington, DC, Sept. 19, 2023 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Center for Studies on New Religions, Human Rights and Religious Freedom Experts Decry Government Persecution of...
The Human Rights and Rights to Religious Freedom of 600,000 Japanese Citizens are at Risk
September 19, 2023 14:07 ET
|
Center for Studies on New Religions, "Bitter Winter"
Washington, DC, Sept. 19, 2023 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Center for Studies on New Religions, Human Rights and Religious Freedom Experts Decry Government Persecution of...
ClimateAi Announces Expanded Presence in Japan to Advance Climate Resilience Solutions
September 14, 2023 07:00 ET
|
ClimateAi
SAN FRANCISCO, Sept. 14, 2023 (GLOBE NEWSWIRE) -- ClimateAi, one of the fastest-growing climate resilience software service providers, today announced the expansion of its presence in Japan with a...
サリプロ・バイオテック (Salipro Biotech)、住友ファーマと研究提携を締結し、創薬プログラムを推進
September 12, 2023 02:00 ET
|
Salipro Biotech AB
本提携では、サリプロ・バイオテックの独自の専門知識とSalipro®プラットフォーム技術を活用して困難な薬物標的を安定化し、住友ファーマの創薬プログラムによる化合物の薬理学的特性を研究 する。 スウェーデン・ストックホルム発, Sept. 12, 2023 (GLOBE NEWSWIRE) -- スウェーデンのバイオテクノロジー企業であるサリプロ・バイオテックAB (Salipro...
Salipro Biotech geht Forschungskooperation mit Sumitomo Pharma zum Vorantreiben eines Medikamentenentwicklungsprogramms ein
September 12, 2023 02:00 ET
|
Salipro Biotech AB
Die Zusammenarbeit nutzt die einzigartige Expertise von Salipro Biotech und die Salipro®-Plattformtechnologie zur Stabilisierung eines anspruchsvollen Wirkstoffziels, um die pharmakologischen...
Salipro Biotech collabore avec Sumitomo Pharma pour développer un programme de recherche de médicaments
September 12, 2023 02:00 ET
|
Salipro Biotech AB
La collaboration mobilise l'expertise unique de Salipro Biotech et sa plateforme technologique Salipro® pour stabiliser une cible pharmacologique difficile. Objectif : étudier les caractéristiques...
Salipro Biotech enters into research collaboration with Sumitomo Pharma to advance a drug discovery program
September 12, 2023 02:00 ET
|
Salipro Biotech AB
The collaboration leverages Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilize a challenging drug target to investigate the pharmacological characteristics of a...
Matterport’s Digital Twin Platform Documents Reconstruction of 2,000 Year-Old Aso Shrine Following Earthquake Collapse
September 05, 2023 09:00 ET
|
Matterport Inc
SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Matterport, Inc. (Nasdaq: MTTR), today announced it has captured the restored Aso Shrine Gate and surrounding shrine area as part of an...
Japan House Announces L.A. Premiere of “Edo Avant Garde”
August 29, 2023 09:00 ET
|
JAPAN HOUSE Los Angeles
LOS ANGELES, Aug. 29, 2023 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles proudly presents the Los Angeles premiere of the documentary “Edo Avant Garde” on Wednesday, September 20 at 6:00PM at the TCL...
Beamr and J21 Corporation Expand Partnership to Distribute Beamr’s Video Cloud Service in Japan
August 08, 2023 07:00 ET
|
Beamr Imaging Ltd.
Herzeliya, Israel, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd (NASDAQ: BMR), a leading provider of video encoding solutions, announced today that J21 Corporation, a business development...